Inhibition of the angiotensin II type 2 receptor AT(2)R is a novel therapeutic strategy for glioblastoma.

Perryman R, Renziehausen A, Shaye H, Kostagianni AD, Tsiailanis AD, Thorne T, Chatziathanasiadou MV, Sivolapenko GB, El Mubarak MA, Han GW, Zarzycka B, Katritch V, Lebon G, Lo Nigro C, Lattanzio L, Morse SV, Choi JJ, O'Neill K, Kanaki Z, Klinakis A, Crook T, Cherezov V, Tzakos AG, Syed N

Open source

DOI: 10.1073/pnas.2116289119
Published: 2022 Aug 9
Container: Proceedings of the National Academy of Sciences of the United States of America
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1073/pnas.2116289119,
  title = {Inhibition of the angiotensin II type 2 receptor AT(2)R is a novel therapeutic strategy for glioblastoma.},
  author = {Perryman R and Renziehausen A and Shaye H and Kostagianni AD and Tsiailanis AD and Thorne T and Chatziathanasiadou MV and Sivolapenko GB and El Mubarak MA and Han GW and Zarzycka B and Katritch V and Lebon G and Lo Nigro C and Lattanzio L and Morse SV and Choi JJ and O'Neill K and Kanaki Z and Klinakis A and Crook T and Cherezov V and Tzakos AG and Syed N},
  year = {2022},
  journal = {Proceedings of the National Academy of Sciences of the United States of America},
  doi = {10.1073/pnas.2116289119},
  url = {https://doi.org/10.1073/pnas.2116289119}
}

RIS

TY  - JOUR
TI  - Inhibition of the angiotensin II type 2 receptor AT(2)R is a novel therapeutic strategy for glioblastoma.
AU  - Perryman R
AU  - Renziehausen A
AU  - Shaye H
AU  - Kostagianni AD
AU  - Tsiailanis AD
AU  - Thorne T
AU  - Chatziathanasiadou MV
AU  - Sivolapenko GB
AU  - El Mubarak MA
AU  - Han GW
AU  - Zarzycka B
AU  - Katritch V
AU  - Lebon G
AU  - Lo Nigro C
AU  - Lattanzio L
AU  - Morse SV
AU  - Choi JJ
AU  - O'Neill K
AU  - Kanaki Z
AU  - Klinakis A
AU  - Crook T
AU  - Cherezov V
AU  - Tzakos AG
AU  - Syed N
PY  - 2022
JO  - Proceedings of the National Academy of Sciences of the United States of America
DO  - 10.1073/pnas.2116289119
UR  - https://doi.org/10.1073/pnas.2116289119
ER  -

APA

R, P., A, R., H, S., AD, K., AD, T., T, T., MV, C., GB, S., MA, E. M., GW, H., B, Z., V, K., G, L., C, L. N., L, L., SV, M., JJ, C., K, O., Z, K., A, K., T, C., V, C., AG, T., & N, S. (2022). Inhibition of the angiotensin II type 2 receptor AT(2)R is a novel therapeutic strategy for glioblastoma.. Proceedings of the National Academy of Sciences of the United States of America. https://doi.org/10.1073/pnas.2116289119

Source records

pubmed · retrieved 2026-09-26T08:49:14.163Z